CC(=O)OC1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4Cc5cn(S(C)(=O)=O)nc5N[C@@]4(C)CC[C@@H]32)C1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?